Role of MCP-1 in the development of tubulointerstitial fibrosis in patients with primary chronic glomerulonephritis
- 2 September 2021
- journal article
- research article
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 25 (5) , 92-98
Abstract
BACKGROUND.To date, the study of the factors involved in the glomerular-tubular pathological connections leading to damage to the tubulointerstitial tissue is one of the topical areas of nephrology. THE AIM: to study the effect of MCP-1 in the development of tubulointerstitial fibrosis as a factor in the irreversible progression of chronic renal failure. PATIENTS ANDMETHODS.Prospective observation and retrospective analysis of case histories were carried out, which included a total of 75 patients with primary chronic glomerulonephritis. RESULTS.The average age of the patients was 36.7 ± 12.3 years, of which 52 were males, 23 were women. The average length of service in a nephrological disease was 3.0 [1.0; 5.0] years. The calculated GFR values are 87.3 ± 31.2 ml / min / 1.73 m2. In the general population, the moderate degree of MCP-1 expression, estimated at 2 points, was 35 %, pronounced expression was found in 25 % of the respondents. In the mesangium of the glomeruli and in macrophages, the expressed degree of MCP-1 expression was 20 % and 16 %, respectively, which characterizes MCP-1 as a marker produced by resident cells. When studying the relationship of MCP-1 in blood with clinical parameters, a correlation was found with the values of total protein (Rs= –0.43; p CONCLUSION.The relationship of serum and tissue forms of MCP-1 with the progression of tubulointerstitial fibrosis in chronic glomerulonephritis has been demonstrated. MCP-1-induced mesangial cell plays a critical role in the development of renal tubular damage, and its increased expression is associated with progressive tubulointerstitial fibrosis and decreased renal function.Keywords
This publication has 12 references indexed in Scilit:
- State of the nephrological service: renal replacement therapy in the Russian Federation from 2015 to 2019Nephrology, 2020
- Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived MacrophagesJournal of Visualized Experiments, 2019
- Management of chronic kidney disease in the Russian Federation: A critical review of prevalence and preventive programmesInternational Journal of Healthcare Management, 2018
- The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summaryClinical Kidney Journal, 2018
- THE RELATIONSHIP OF MCP-1 AND TUBULOINTERSTITIAL FIBROSIS IN CHRONIC GLOMERULONEPHRITISNephrology (Saint-Petersburg), 2017
- Monocyte chemoattractant protein-1: its role in the development of tubulointerstitial fibrosis in nephropathiesMedical news of the North Caucasus, 2017
- Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary GlomerulonephritisKidney and Blood Pressure Research, 2016
- Genetic variants of MCP-1 and CCR2 genes and IgA nephropathy riskOncotarget, 2016
- Monocyte chemoattractant protein-1 and the kidneyCurrent Opinion in Nephrology and Hypertension, 2016
- Chemokines and GlycosaminoglycansFrontiers in Immunology, 2015